Guilherme Magnavita

Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study

Fernanda S. Correia‐Melo, Gustavo C. Leal, Flávia Vieira et al. · Journal of Affective Disorders · 2019 · 187 citations

Pharmacy, Pharmacology, Psychiatry +16

Comparative study of esketamine and racemic ketamine in treatment-resistant depression

Fernanda S. Correia‐Melo, Gustavo C. Leal, Michelle S. Carvalho et al. · Medicine · 2018 · 61 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Feasibility of Transcranial Direct Current Stimulation Use in Children Aged 5 to 12 Years

Agnes Carvalho Andrade, Guilherme Magnavita, Juleilda Valéria Brasil Nunes Allegro et al. · Journal of Child Neurology · 2013 · 59 citations

Medicine, Pediatrics, Psychiatry +14

Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study

Lucas Araújo-de-Freitas, Cassio Santos‐Lima, Euclides Mendonça-Filho et al. · Psychiatry Research · 2021 · 38 citations

Medicine, Pharmacology, Psychiatry +16

Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial

Rodrigo P. Mello, Mariana V.F. Echegaray, Ana Paula Jesus‐Nunes et al. · Journal of Psychiatric Research · 2021 · 22 citations

Pharmacy, Psychiatry, Psychology +17